2012
DOI: 10.2214/ajr.11.7040
|View full text |Cite
|
Sign up to set email alerts
|

Nonsurgical Management of High-Risk Lesions Diagnosed at Core Needle Biopsy: Can Malignancy Be Ruled Out Safely With Breast MRI?

Abstract: Patients with high-risk lesions associated with the lowest likelihood of malignancy (papilloma and radial scar) and without suspicious MRI findings can safely undergo follow-up instead of surgery. Because of the low negative predictive value, however, MRI is not helpful in cases of lobular neoplasia and atypical ductal hyperplasia, and all these lesions should be excised.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
33
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 74 publications
(35 citation statements)
references
References 32 publications
2
33
0
Order By: Relevance
“…The upgrade rate to malignancy was lower for papillomas and radial scars in our study (no cancers found in both entities), which is similar to the data reported in the literature [24]. Linda et al have concluded from their study that patients with papillomas or radial scars on percutaneous biopsy may not need to undergo surgical excision if MRI is negative [26]. When using MRI to predict whether surgical excision is necessary in patients with highrisk lesions classified as B3 on percutaneous biopsy, it is important to realize that MRI will probably have a higher accuracy if performed prior to biopsy as in our study rather than after percutaneous biopsy, since changes related to biopsy, which might impair the diagnostic accuracy of MRI, can be avoided by performing MRI prior to biopsy.…”
Section: Tab 3 Diagnostische Genauigkeit Der Mrt-befunde Insupporting
confidence: 90%
“…The upgrade rate to malignancy was lower for papillomas and radial scars in our study (no cancers found in both entities), which is similar to the data reported in the literature [24]. Linda et al have concluded from their study that patients with papillomas or radial scars on percutaneous biopsy may not need to undergo surgical excision if MRI is negative [26]. When using MRI to predict whether surgical excision is necessary in patients with highrisk lesions classified as B3 on percutaneous biopsy, it is important to realize that MRI will probably have a higher accuracy if performed prior to biopsy as in our study rather than after percutaneous biopsy, since changes related to biopsy, which might impair the diagnostic accuracy of MRI, can be avoided by performing MRI prior to biopsy.…”
Section: Tab 3 Diagnostische Genauigkeit Der Mrt-befunde Insupporting
confidence: 90%
“…In most studies, the rate of upgrade, or underestimation of malignancy, of surgically excised radial scars has been variable, but most reported rates are in the range of 0% to 10%. 3,[5][6][7][8][9][10][11][12][13][14] However, most radiologists are not comfortable recommending clinical follow-up over surgical excision of radial scars because studies have not consistently demonstrated an upgrade rate of less than 2%, the cutoff for categorizing a lesion as ''probably benign'' according to the BI-RADS (Breast Imaging Reporting and Data System) system (BI-RADS 3). 15 The variability in reported upgrade rates may be due to several factors including variability in study design, small sample sizes, and inconsistent radiologic-pathologic concordance.…”
Section: Commentmentioning
confidence: 99%
“…3,6,7,16 It is also worthy to note that even the high-risk lesions (LCIS, ADH, ALH) considered as pathologic upgrades could, themselves, be considered incidental microscopic findings, as they would have remained clinically occult had an excisional biopsy not been performed in these cases.…”
Section: Commentmentioning
confidence: 99%
“…However, data on high-risk lesions from MRI-guided biopsies, including ADH, ALH, flat epithelial atypia (FEA), and LCIS are limited. [6][7][8][9][10] The purpose of our study was to determine the frequency of high-risk histopathologic features resulting from MRI-guided core needle biopsy, the subsequent upstage rates to malignancy, and whether the imaging characteristics could help predict upstage rates.…”
Section: Introductionmentioning
confidence: 99%